TLR4 and atherosclerosis: Toll-like receptors can initiate inflammatory responses in atherosclerosis and STAT-1 is involved in the signaling pathways mediated by toll-like receptor 4, resulting in increased expression of several pro-inflammatory and pro-atherogenic mediators.